Asia Set To Become New Center Of Pharma: PricewaterhouseCoopers Report
This article was originally published in PharmAsia News
Asia is poised to become the new center of the global pharmaceutical industry, according to a PricewaterhouseCoopers report, with China and India set to be the largest beneficiaries
You may also be interested in...
Ranbaxy will develop a respiratory disease candidate through proof of concept under an expanded discovery agreement inked with GSK in February.
Firm is looking to increase deal flow in developing markets, company exec tells BIO Asia conference in Tokyo.
Singapore Biomedical Sciences Group Director Yeoh Keat Chuan: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
Singapore government official talks about the country’s R&D strengths and how it is handling increased competition from other Asian nations.